Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD-AF registry

Jaap Seelig*, Martin E. W. Hemels, Olivier Xhaet, Maarten C. M. Bongaerts, Axel de Wolf, Bjorn E. Groenemeijer, Alex Heyse, Pieter Hoogslag, Joeri Voet, Jean-Paul R. Herrman, Geert Vervoort, Walter Hermans, Bart Wollaert, Lucas V. A. Boersma, Kurt Hermans, Andreas Lucassen, Stefan Verstraete, Henk J. Adriaansen, Georges H. Mairesse, Willem F. TerpstraDirk Faes, Mathijs Pieterse, Saverio Virdone, Freek W. A. Verheugt, Frank Cools, Hugo ten Cate, GARFIELD-AF Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3280-3288
Number of pages9
JournalJournal of Thrombosis and Haemostasis
Volume18
Issue number12
Early online date25 Sep 2020
DOIs
Publication statusPublished - Dec 2020

Keywords

  • anticoagulants
  • hemorrhage
  • international normalized ratio
  • registries
  • stroke
  • VENOUS THROMBOEMBOLIC DISEASE
  • ORAL ANTICOAGULANTS
  • STROKE
  • RISK
  • METAANALYSIS
  • DEFINITION
  • INTENSITY
  • WARFARIN
  • THERAPY
  • SAFETY

Cite this